Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vista PD
NCT07804615Phase 2Recruiting
- Sponsor
- Vima Therapeutics
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 2
01
Overview
A Phase 2 trial of VIM0423 in Parkinson's disease (PD), sponsored by Vima Therapeutics. Started Sep 2026; status: recruiting.
02
Drugs
VIM0423
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07804615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804615.